JD Supra: Mergers
MARCH 31, 2025
Welcome to our ninth annual report on US securities class actions filed against publicly traded life sciences companies, which include pharmaceutical, biotechnology, medical device, and healthcare companies. By: Goodwin
Global Newswire by Notified: M&A
JULY 24, 2023
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
How2Exit
MARCH 31, 2024
Get the Insider Tips You Need to Secure Your Deal - Watch Here rn rn About the Guest(s): rn Patrick O'Connell is an experienced mergers and acquisitions (M&A) advisor with a profound depth of knowledge in buying and selling small businesses valued between one to $20 million. b' E200: Buying or Selling a Small Business?
Global Newswire by Notified: M&A
JANUARY 12, 2024
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3
Global Newswire by Notified: M&A
JANUARY 9, 2024
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3
Global Newswire by Notified: M&A
JANUARY 3, 2024
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3
Cooley M&A
JULY 10, 2017
Therefore, buyers should be cognizant of these securities law considerations and some of their practical implications. If the right to be paid contingent consideration is transferable, that right will likely be considered a “security” of the buyer under long-held SEC guidance. Private placement. earn-out rights).
Expert insights. Personalized for you.
183 
Let's personalize your content